National Oilwell Varco
was upgraded at Societe Generale from Hold to Buy. $85 price target. Stock has underperformed its peers of late, Societe Generale said.
was initiated with an Outperform rating at Bernstein. $74 price target. Carfilzomib should ultimately help drive the company toward profitability, Bernstein said.
(PPG - Get Report)
was upgraded from Neutral to Buy at Bank of America/Merrill Lynch. $115 price target. Stock has pulled back, and the company should see lower raw material costs, BofA/Merrill said.
was downgraded at JP Morgan from Overweight to Neutral. $26 price target. Valuation call, as the stock is already up 61% on the year, JP Morgan said.
was upgraded to Neutral from Sell at UBS. $54 price target. Stock is now near its fair price, UBS said.
was upgraded at Wells Fargo from Market Perform to Outperform. Actavis acquisition should create higher earnings power, Wells said.
STOCK COMMENTS / EPS CHANGES
numbers were increased at Piper Jaffray. Company boosted its guidance, Piper Jaffray said. Overweight rating and new $24 price target.
numbers were lowered at Citigroup. Shares are now seen reaching $180. Estimates were also lowered as secondary absorbed significant demand and few near-term catalysts, Citi said.
was added to Select List at Stifel Nicolaus. Acquisitions should help boost growth, Stifel Nicolaus said. $71 price target.
numbers were cut at BMO. Estimates were reduced through 2013. Company is leveraged to weaker equity market performance, BMO said. Market Perform rating.
estimates, price target were raised at Sterne Agee. Estimates were boosted through 2014. Company is seeing favorable sales trends, Sterne Agee said. Buy rating and new $85 price target.
numbers were raised at Sterne Agee. Shares are now seen reaching $33. Estimates were also increased, as management appears to be turning the business around, Sterne Agee said. Buy rating.
numbers were lowered at Jefferies. Shares are now seen reaching $46. Estimates were also lowered on skepticism over growth projects, Jefferies said. Hold rating.
estimates, price target were reduced at Credit Suisse. Shares are now seen reaching $30. Estimates were also cut, given the company's new guidance, Credit Suisse said. Neutral rating.